Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

60 Degrees Pharmaceuticals (SXTP) Return on Assets (2023 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Return on Assets for 3 consecutive years, with 0.11% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets rose 73.0% to 0.11% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.11%, a 73.0% increase, with the full-year FY2024 number at 0.09%, up 9.0% from a year prior.
  • Return on Assets was 0.11% for Q3 2025 at 60 Degrees Pharmaceuticals, down from 0.09% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.27% in Q1 2024 to a low of 0.84% in Q3 2024.
  • A 3-year average of 0.18% and a median of 0.1% in 2023 define the central range for Return on Assets.
  • Biggest YoY gain for Return on Assets was 73bps in 2025; the steepest drop was -77bps in 2025.
  • 60 Degrees Pharmaceuticals' Return on Assets stood at 0.1% in 2023, then increased by 7bps to 0.09% in 2024, then decreased by -26bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Return on Assets are 0.11% (Q3 2025), 0.09% (Q2 2025), and 0.49% (Q1 2025).